Literature DB >> 26178809

Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.

Ellen 't Hoen1, Fernando Pascual2.   

Abstract

New interest in the 'pandemic' of falsified medicines has resulted in efforts to put in place a treaty on 'medicines crime'. If the goal is to protect the interests of people and public health, an international agreement to ensure that all proven effective and necessary medicines are affordable, available, and of assured quality will do far more to combat falsified and substandard medicines than an agreement that deals primarily with the criminal aspects of problematic medicines production and distribution.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26178809     DOI: 10.1057/jphp.2015.22

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  4 in total

Review 1.  Substandard medicines in resource-poor settings: a problem that can no longer be ignored.

Authors:  J-M Caudron; N Ford; M Henkens; C Macé; R Kiddle-Monroe; J Pinel
Journal:  Trop Med Int Health       Date:  2008-07-08       Impact factor: 2.622

2.  A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.

Authors:  Ellen F M 't Hoen; Hans V Hogerzeil; Jonathan D Quick; Hiiti B Sillo
Journal:  J Public Health Policy       Date:  2014-01-16       Impact factor: 2.222

3.  A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.

Authors:  Brenda Waning; Ellen Diedrichsen; Suerie Moon
Journal:  J Int AIDS Soc       Date:  2010-09-14       Impact factor: 5.396

4.  The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives.

Authors:  Gaurvika M L Nayyar; Joel G Breman; James E Herrington
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

  4 in total
  7 in total

1.  Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.

Authors:  Raffaella Ravinetto; Daniel Vandenbergh; Cécile Macé; Corinne Pouget; Brigitte Renchon; Jean Rigal; Benedetta Schiavetti; Jean-Michel Caudron
Journal:  J Pharm Policy Pract       Date:  2016-11-10

2.  The Quality of Medicines Used in Children and Supplied by Private Pharmaceutical Wholesalers in Kinshasa, Democratic Republic of Congo: A Prospective Survey.

Authors:  Benedetta Schiavetti; Evelien Wynendaele; Bart De Spiegeleer; Geremie J Mbinze; Nicodème Kalenda; Roland Marini; Vera Melotte; Epco Hasker; Bruno Meessen; Raffaella Ravinetto; Josiane Van der Elst; Daniel Mutolo Ngeleka
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

3.  Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India.

Authors:  Praveen Kumar Aivalli; Maya Annie Elias; Manoj Kumar Pati; Srinath Bhanuprakash; Chikkagollahalli Munegowda; Zubin Cyrus Shroff; Prashanth N Srinivas
Journal:  BMJ Glob Health       Date:  2018-01-13

4.  Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.

Authors:  Elizabeth Pisani; Adina-Loredana Nistor; Amalia Hasnida; Koray Parmaksiz; Jingying Xu; Maarten Oliver Kok
Journal:  Wellcome Open Res       Date:  2019-04-16

5.  Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.

Authors:  Eugenia Olliaro; Piero Olliaro; Calvin W L Ho; Raffaella Ravinetto
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

6.  Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint.

Authors:  Raffaella Ravinetto; Anja De Weggheleire; Thomas P C Dorlo; Sven Francque; An Sokkab; Corinne Pouget; Bruno Meessen; Patricia Tabernero; Paul N Newton; Lut Lynen
Journal:  Trop Med Int Health       Date:  2016-10-17       Impact factor: 2.622

7.  A survey of nongovernmental organizations on their use of WHO's prequalification programme.

Authors:  Ariadna Nebot Giralt; Maya Ronse; Raffaella Ravinetto
Journal:  Bull World Health Organ       Date:  2020-04-07       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.